These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19679545)

  • 1. Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
    Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
    Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEK oncogene is overexpressed during melanoma progression.
    Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
    Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
    Feng T; Liu Y; Li C; Li Z; Cai H
    Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.
    Wise-Draper TM; Allen HV; Jones EE; Habash KB; Matsuo H; Wells SI
    Mol Cell Biol; 2006 Oct; 26(20):7506-19. PubMed ID: 16894028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of tumorigenesis and chemoresistance by the DEK oncogene.
    Riveiro-Falkenbach E; Soengas MS
    Clin Cancer Res; 2010 Jun; 16(11):2932-8. PubMed ID: 20501624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEK expression in melanocytic lesions.
    Kappes F; Khodadoust MS; Yu L; Kim DS; Fullen DR; Markovitz DM; Ma L
    Hum Pathol; 2011 Jul; 42(7):932-8. PubMed ID: 21316078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
    Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
    PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
    Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
    Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogene DEK promotes leukemic cell survival and is downregulated by both Nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells.
    Secchiero P; Voltan R; di Iasio MG; Melloni E; Tiribelli M; Zauli G
    Clin Cancer Res; 2010 Mar; 16(6):1824-33. PubMed ID: 20215548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mcl-1 is required for melanoma cell resistance to anoikis.
    Boisvert-Adamo K; Longmate W; Abel EV; Aplin AE
    Mol Cancer Res; 2009 Apr; 7(4):549-56. PubMed ID: 19372583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human DEK oncogene regulates DNA damage response signaling and repair.
    Kavanaugh GM; Wise-Draper TM; Morreale RJ; Morrison MA; Gole B; Schwemberger S; Tichy ED; Lu L; Babcock GF; Wells JM; Drissi R; Bissler JJ; Stambrook PJ; Andreassen PR; Wiesmüller L; Wells SI
    Nucleic Acids Res; 2011 Sep; 39(17):7465-76. PubMed ID: 21653549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.
    Privette Vinnedge LM; McClaine R; Wagh PK; Wikenheiser-Brokamp KA; Waltz SE; Wells SI
    Oncogene; 2011 Jun; 30(24):2741-52. PubMed ID: 21317931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells.
    Sarif Z; Tolksdorf B; Fechner H; Eberle J
    Mol Carcinog; 2020 Nov; 59(11):1256-1268. PubMed ID: 32885857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBPα and DEK coordinately regulate myeloid differentiation.
    Koleva RI; Ficarro SB; Radomska HS; Carrasco-Alfonso MJ; Alberta JA; Webber JT; Luckey CJ; Marcucci G; Tenen DG; Marto JA
    Blood; 2012 May; 119(21):4878-88. PubMed ID: 22474248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.
    Qian Z; Yang J; Liu H; Yin Y; Hou L; Hu H
    Folia Histochem Cytobiol; 2019; 57(2):64-73. PubMed ID: 31246264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1.
    Senft D; Berking C; Graf SA; Kammerbauer C; Ruzicka T; Besch R
    PLoS One; 2012; 7(1):e30821. PubMed ID: 22292048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.
    Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB
    J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo.
    Wise-Draper TM; Mintz-Cole RA; Morris TA; Simpson DS; Wikenheiser-Brokamp KA; Currier MA; Cripe TP; Grosveld GC; Wells SI
    Cancer Res; 2009 Mar; 69(5):1792-9. PubMed ID: 19223548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in studies on the DEK protein and its involvement in cellular apoptosis.
    Hua Y; Hu H; Peng X
    Sci China C Life Sci; 2009 Jul; 52(7):637-42. PubMed ID: 19641868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.